Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care
- PMID: 18782405
- DOI: 10.1111/j.1753-6405.2008.00260.x
Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care
Abstract
Objectives: To investigate incidence, mortality and case survival trends for cancer of unknown primary site (CUP) and consider clinical implications.
Method: South Australian Cancer Registry data were used to calculate age-standardised incidence and mortality rates from 1977 to 2004. Disease-specific survivals, socio-demographic, histological and secular predictors of CUP, compared with cancers of known primary site, and of CUP histological types, using multivariable logistic regression were investigated.
Results: Incidence and mortality rates increased approximately 60% between 1977--80 and 1981--84. Rates peaked in 1993--96. Male to female incidence and mortality rate ratios approximated 1.3:1. Incidence and mortality rates increased with age. The odds of unspecified histological type, compared with the more common adenocarcinomas, were higher for males than females, non-metropolitan residents, low socio-economic areas, and for 1977--88 than subsequent diagnostic periods. CUP represented a higher proportion of cancers in Indigenous patients. Case survival was 7% at 10 years from diagnosis. Factors predictive of lower case survival included older age, male sex, Indigenous status, lower socio-economic status, and unspecified histology type.
Conclusion: Results point to poor CUP outcomes, but with a modest improvement in survival. The study identifies socio-demographic groups at elevated risk of CUP and of worse treatment outcomes where increased research and clinical attention are required.
Similar articles
-
Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.Acta Oncol. 2009;48(6):915-20. doi: 10.1080/02841860902862503. Acta Oncol. 2009. PMID: 19363713
-
The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.Cancer. 2006 May 1;106(9):2058-66. doi: 10.1002/cncr.21833. Cancer. 2006. PMID: 16583433
-
Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men?BJU Int. 2009 Aug;104(4):498-504. doi: 10.1111/j.1464-410X.2009.08527.x. Epub 2009 Mar 31. BJU Int. 2009. PMID: 19338538
-
Thyroid cancer.Cancer Surv. 1994;19-20:393-422. Cancer Surv. 1994. PMID: 7534634 Review.
-
Cancer of unknown primary site.Aust Fam Physician. 2015 Sep;44(9):640-3. Aust Fam Physician. 2015. PMID: 26488041 Review.
Cited by
-
Changes in cancer incidence and mortality in Australia over the period 1996-2015.BMC Res Notes. 2020 Dec 10;13(1):561. doi: 10.1186/s13104-020-05395-6. BMC Res Notes. 2020. PMID: 33303018 Free PMC article.
-
Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.Clin Exp Metastasis. 2013 Apr;30(4):431-9. doi: 10.1007/s10585-012-9548-3. Epub 2012 Nov 4. Clin Exp Metastasis. 2013. PMID: 23124598 Clinical Trial.
-
Extent of diagnostic inquiry among a population-based cohort of patients with cancer of unknown primary.Cancer Rep Rev. 2019 Sep;3(3). doi: 10.15761/CRR.1000187. Epub 2019 Jul 8. Cancer Rep Rev. 2019. PMID: 31828233
-
Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities.Br J Cancer. 2013 Sep 3;109(5):1318-24. doi: 10.1038/bjc.2013.386. Epub 2013 Jul 16. Br J Cancer. 2013. PMID: 23860528 Free PMC article.
-
Metastatic tumors to the jaws and mouth.Head Neck Pathol. 2014 Dec;8(4):463-74. doi: 10.1007/s12105-014-0591-z. Epub 2014 Nov 20. Head Neck Pathol. 2014. PMID: 25409855 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources